<DOC>
	<DOCNO>NCT00686114</DOCNO>
	<brief_summary>This study multi-center randomized phase III one evaluate difference local-control survival rate patient receive concurrent chemoradiotherapy combine Tarceva .</brief_summary>
	<brief_title>Concurrent Chemoradiotherapy Containing Paclitaxel &amp; Cisplatin With/Without Tarceva Locally Advanced Esophageal Cancer</brief_title>
	<detailed_description>For esophageal carcinoma II~III stage , routine dosage Paclitaxel platinum medicine chemotherapy concurrently radical radiotherapy worthy study . On base , advance approach enlarge field radiotherapy intervention Tarceva . And approach therapeutic effect method theoretically , may give reasonable guidance clinical therapy .</detailed_description>
	<mesh_term>Esophageal Neoplasms</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Erlotinib Hydrochloride</mesh_term>
	<criteria>1 . Subjects must confirm Esophageal Carcinoma pathologically 2 . ( EUS ) I～IVa , without contraindication radical radiotherapy 3 . Subjects n't give neither radiotherapy chemotherapy 4 . Age 1870 , behavioral status evaluation ECOG score 0—2 anticipated survival 6 month 5 . In 7 day select , subject follow status : WBC ≥ 4.0 x 10^9/L ; ANC ≥ 1.5x 10^9/L ; PLT ≥ 100 x 10^9/L ; Hb ≥ 90 g/L ; serum Cr ≤ ULN ; serum bilirubin ≤ 1.5 ULN ; ALT/AST ≤ 1.5 ULN 6 . Subjects sign inform consent 7 . Subjects perform good compliance 8 . Male female subject ability fertility take contraception whole course also 3 month last dosage.In 7 day inclusion , urine pregnancy test subject negative . 1 . Patients currently undergo additional chemotherapy , radiation therapy target therapy 2 . Complete obstruction esophagus , patient potential develop perforation 3 . Patients history malignancy ( except skin carcinoma situ breast cancer , oral cancer cervical cancer expect survival ≥2 year 4 . Patients multiple foci esophagus 5 . Patients are/were give medicine test currently/in last 4 week 6 . Experienced hypersensitiveness similar medicine kind biomedicines 7 . Women status pregnancy 8 . Patients complication exist follow : ( 1 ) Uncontrolled angina heart failure , history hospitalization 3 month ; ( 2 ) A history myocardial infarction past 6 month ; ( 3 ) There need antibiotic treatment acute bacterial fungal infection ; ( 4 ) Chronic obstructive pulmonary disease , lung disease require hospitalization ; ( 5 ) Drug addiction , alcoholism AIDS disease longterm virus carrier ; ( 6 ) Uncontrollable seizure , loss insight mental illness</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>Esophageal cancer</keyword>
	<keyword>chemoradiation</keyword>
	<keyword>radiosensitivity</keyword>
	<keyword>EGFR inhibition</keyword>
</DOC>